Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2012
08/09/2012WO2012106534A2 Hiv integrase inhibitors
08/09/2012WO2012106509A1 Sirtuin modulators as virus production modulators
08/09/2012WO2012106251A2 Pertussis vaccine
08/09/2012WO2012106190A1 C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
08/09/2012WO2012106188A1 C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors
08/09/2012WO2012105873A1 Hydrated n-fullerene amino acids, method for producing the latter, and pharmaceutical compositions on the basis thereof
08/09/2012WO2012105872A1 Homo- and hetero-polyamino-acid derivatives of fullerene с60, method for producing same, and pharmaceutical compositions based on said derivatives
08/09/2012WO2012105708A1 Novel crystal of tetrahydronaphthalene compound
08/09/2012WO2012105563A1 Veterinary drug comprising macrolide derivative
08/09/2012WO2012105562A1 Novel macrolide derivative
08/09/2012WO2012105467A1 Oligonucleic acid composition and antiallergic agent
08/09/2012WO2012104793A1 An antibacterial and antiviral compound
08/09/2012WO2012104738A2 Feminine care absorbent article for use in warm climates
08/09/2012WO2012104571A1 Compositions of monoterpenoids for the treatment of influenza
08/09/2012WO2012104570A1 Composition of monoterpenoids having bactericidal properties
08/09/2012WO2012104569A1 Composition of monoterpenoids for the treatment of cancer
08/09/2012WO2012104568A1 Compositions of monoterpenoids for stimulating the immune system
08/09/2012WO2012104567A1 Compositions of monoterpenoids for the treatment of an hiv infection
08/09/2012WO2012104355A1 Antiviral agent containing recombinant mistletoe lectins
08/09/2012WO2012104305A1 Antimicrobial 4-oxoquinolizines
08/09/2012WO2012103813A1 Danshensu and chuanxiongqin derivatives, process for preparation, and use thereof
08/09/2012WO2012103802A1 Liquid medicinal composition containing echinocandin antifungal agent micafungin
08/09/2012WO2012103801A1 Medicinal composition containing echinocandin antifungal agent micafungin, and preparation method and use therefor
08/09/2012WO2012103800A1 Method for preparing cyclic lipopeptide compound
08/09/2012WO2012103684A1 Fusion proteins and methods for treating hiv infection and aids related symptoms
08/09/2012WO2012070798A3 Topical antifungal composition comprising terbinafine or its salt
08/09/2012WO2012044531A8 Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals
08/09/2012WO2010075549A3 Nucleoside phosphoramidates
08/09/2012US20120202980 Novel Flavanone Derivative
08/09/2012US20120202887 Facially Amphiphilic Polyaryl and Polyarylalkynyl Polymers and Oligomers and Uses Thereof
08/09/2012US20120202877 Anti-influenza agents
08/09/2012US20120202871 Cationic lipids and methods for the delivery of therapeutic agents
08/09/2012US20120202869 Antidepressant Oral Pharmaceutical Compositions
08/09/2012US20120202862 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
08/09/2012US20120202859 Macrocyclic Inhibitors of Hepatitis C Virus
08/09/2012US20120202858 Solid Pharmaceutical Dosage Form
08/09/2012US20120202857 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
08/09/2012US20120202847 Novel Tetrahydroisoquinoline Compounds
08/09/2012US20120202841 Topical Compositions Comprising Ascomycins
08/09/2012US20120202814 Compounds with ddx3 inhibitory activity and uses thereof
08/09/2012US20120202809 Novel n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as pkc kinase inhibitors
08/09/2012US20120202805 PI3K (delta) SELECTIVE INHIBITORS
08/09/2012US20120202802 Spirocyclic compounds as modulators of chemokine receptor activity
08/09/2012US20120202794 Compounds
08/09/2012US20120202792 Antimicrobial Compounds and Methods of Making and Using the Same
08/09/2012US20120202790 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
08/09/2012US20120202785 Heterocyclic compounds and methods of use
08/09/2012US20120202777 C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents
08/09/2012US20120202775 Substituted indole and azaindole oxoacetyl piperazinamide derivatives
08/09/2012US20120202771 Therapeutic agent for influenza virus infection diseases
08/09/2012US20120202766 N4-acylcytosine nucleosides for treatment of viral infections
08/09/2012US20120202763 Methods for treating cancer and non-neoplastic conditions
08/09/2012US20120202758 Core 2glcnac-t inhibitors
08/09/2012US20120202756 Use of prodrugs to avoid gi mediated adverse events
08/09/2012US20120202738 Therapy for enteric infections
08/09/2012US20120202737 New bacitracin antibiotics
08/09/2012US20120202736 Spray-dried collectin compositions and process for preparing the same
08/09/2012US20120202735 Antimicrobial cationic peptides and formulations thereof
08/09/2012US20120202734 Antibiotic, its nucleotide sequence, methods of construction and uses thereof
08/09/2012US20120202695 Core stabilized microcapsules, method of their preparation and uses thereof
08/09/2012US20120201916 Quality of life of hepatitis C patients with a formulation for administration to the oral mucosa including freeze dried lysate of selected Lactobacillus or Bifidobacterium species and N-acetyl D-glucosamine
08/09/2012US20120201914 Method and Composition for Improving Animal Oral Health
08/09/2012US20120201913 Methods and products using grass of the genus triodia
08/09/2012US20120201911 Herbal composition comprising ginger and goldenrod for the treatment of cold and flu
08/09/2012US20120201901 Topical Antibiotic Formulations
08/09/2012US20120201883 Antiviral compositons
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201869 Marine bacterial substances, medical devices, and methods for biofilm inhibition
08/09/2012US20120201868 Treatment and prevention of hiv infection
08/09/2012US20120201866 Cistus extracts
08/09/2012US20120201862 Process for the preparation of colloidal systems for the delivery of active compounds
08/09/2012US20120201853 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins
08/09/2012US20120201852 Vaccines Against Japanese Encephalitis Virus and West Nile Virus
08/09/2012US20120201849 Vaccine stabilizer
08/09/2012US20120201847 Vaccine Formulations and Uses Thereof
08/09/2012US20120201846 Polymer particles and uses thereof
08/09/2012US20120201845 Transcutaneous immunization without heterologous adjuvant
08/09/2012US20120201844 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/09/2012US20120201834 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
08/09/2012US20120201833 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201829 Human Monoclonal Antibody Against S. Aureus Derived Alpha-Toxin and Its Use in Treating or Preventing Abscess Formation
08/09/2012US20120201825 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201811 Generation and use of fab, scfv, and related binding molecules specific for hiv-1 rev
08/09/2012US20120201806 Liquid-retaining elastomeric compositions
08/09/2012US20120201800 Methods and Devices for Sustained In-Vivo Release Of an Active Agent
08/09/2012US20120201798 Compositions and methods and uses related thereto
08/09/2012US20120201794 Dual vector for inhibition of human immunodeficiency virus
08/09/2012US20120201783 Compounds for the treatment of hepatitis c
08/09/2012US20120201782 Peptide, adjuvants, vaccines, and methods of use
08/09/2012US20120201748 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
08/09/2012CA2826662A1 Treatment of bacterial infections
08/09/2012CA2826257A1 C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors
08/09/2012CA2826174A1 Novel macrolide derivative
08/09/2012CA2826113A1 C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
08/09/2012CA2826037A1 Method for preparing cyclic lipopeptide compound
08/09/2012CA2810515A1 Hydrated n-fullerene amino acids, method for producing the latter, and pharmaceutical compositions on the basis thereof
08/09/2012CA2810507A1 Homo- and hetero-polyamino-acid derivatives of fullerene c60, method for producing same, and pharmaceutical compositions based on said derivatives
08/08/2012EP2484757A1 Virus capable of expressing -galactose epitope, and method for production of vaccine
1 ... 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 ... 1798